140 related articles for article (PubMed ID: 11449844)
41. Interaction between warfarin and oral terbinafine. Manufacturer does not agree that interaction was with terbinafine.
Gantmacher J; Mills-Bomford J; Williams T
BMJ; 1998 Jul; 317(7152):205; author reply 205. PubMed ID: 9665914
[No Abstract] [Full Text] [Related]
42. Onychomycosis. New therapies for an old disease.
Gupta AK; Scher RK; De Doncker P; Sauder DN; Shear NH
West J Med; 1996 Dec; 165(6):349-51. PubMed ID: 9000854
[TBL] [Abstract][Full Text] [Related]
43. A curious case of cholestasis: oral terbinafine associated with cholestatic jaundice and subsequent erythema nodosum.
Kumar K; Gill A; Shafei R; Wright JL
BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25480138
[TBL] [Abstract][Full Text] [Related]
44. Fatal hepatic veno-occlusive disease associated with terbinafine in a liver transplant recipient.
Walter RB; Lukaschek J; Renner EL; Müllhaupt B; Bachli EB
J Hepatol; 2003 Mar; 38(3):373-4. PubMed ID: 12586307
[No Abstract] [Full Text] [Related]
45. Terbinafine-induced lupus erythematosus.
Murphy M; Barnes L
Br J Dermatol; 1998 Apr; 138(4):708-9. PubMed ID: 9640387
[No Abstract] [Full Text] [Related]
46. Loss of taste and terbinafine.
Back D
Lancet; 1992 Jul; 340(8813):252. PubMed ID: 1353184
[No Abstract] [Full Text] [Related]
47. Terbinafine: tolerability in general medical practice.
O'Sullivan DP
Br J Dermatol; 1999 Nov; 141 Suppl 56():21-5. PubMed ID: 10730910
[TBL] [Abstract][Full Text] [Related]
48. [Agranulocytosis during a treatment with terbinafine].
Barete S; Bissuel F; Longuet P; Pocidalo MA; Leport C; Vildé JL
Rev Med Interne; 1997; 18(3):258-9. PubMed ID: 9173473
[No Abstract] [Full Text] [Related]
49. Hypersensitivity reaction to terbinafine.
Gupta AK; Kopstein JB; Shear NH
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):1018-9. PubMed ID: 9204074
[No Abstract] [Full Text] [Related]
50. Itraconazole-induced acute hepatitis in an agricultural worker: susceptibility or drug interaction?
Jiménez-Sáenz M; Villar-Rodríguez JL; del Carmen Martínez-Sánchez M; Rebollo-Bernárdez J; Carmona-Soria I; Herrerías-Esteban JM; Herrerías-Gutiérrez JM
J Clin Gastroenterol; 2004 Apr; 38(4):380-2. PubMed ID: 15087702
[No Abstract] [Full Text] [Related]
51. Terbinafine and fixed drug eruption.
Munn SE; Russell Jones R
Br J Dermatol; 1995 Nov; 133(5):815-6. PubMed ID: 8555044
[No Abstract] [Full Text] [Related]
52. Loss of taste and terbinafine.
Juhlin L
Lancet; 1992 Jun; 339(8807):1483. PubMed ID: 1351157
[No Abstract] [Full Text] [Related]
53. Loss of taste and terbinafine.
Ottervanger JP; Stricker BH
Lancet; 1992 Sep; 340(8821):728. PubMed ID: 1355823
[No Abstract] [Full Text] [Related]
54. Severe pustular psoriasis provoked by oral terbinafine.
Wilson NJ; Evans S
Br J Dermatol; 1998 Jul; 139(1):168. PubMed ID: 9764183
[No Abstract] [Full Text] [Related]
55. [Rhabdomyolisis and terbinafine].
Gallego Peris A; Sanfélix Gimeno G; Palop Larrea V; Sanfélix Genovés J
Med Clin (Barc); 2006 Nov; 127(20):799. PubMed ID: 17198674
[No Abstract] [Full Text] [Related]
56. Inverse psoriasis induced by terbinafine.
Pauluzzi P; Boccucci N
Acta Derm Venereol; 1999 Sep; 79(5):389. PubMed ID: 10494721
[No Abstract] [Full Text] [Related]
57. Taste disorders and terbinafine.
Beutler M; Hartmann K; Kuhn M; Gartmann J
BMJ; 1993 Jul; 307(6895):26. PubMed ID: 8343667
[No Abstract] [Full Text] [Related]
58. Terbinafine-induced liver injury.
Kaushal M; Tolani P; Kumar N; Sharma S
Natl Med J India; 2017; 30(6):321-323. PubMed ID: 30117442
[TBL] [Abstract][Full Text] [Related]
59. Parotid swelling and terbinafine.
Torrens JK; McWhinney PH
BMJ; 1998 Feb; 316(7129):440-1. PubMed ID: 9492671
[No Abstract] [Full Text] [Related]
60. Persistent impairment of taste resulting from terbinafine.
Bong JL; Lucke TW; Evans CD
Br J Dermatol; 1998 Oct; 139(4):747-8. PubMed ID: 9892929
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
